Liver function and drug breakdown: a new study on mirdametinib
NCT ID NCT06997276
First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 4 times
Summary
This study looks at how the drug mirdametinib is absorbed and removed from the body in people with moderate or severe liver problems compared to those with normal liver function. It involves 32 adults and is for research only, not to treat any condition. The goal is to understand safety and how the liver affects the drug's levels in the blood.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
American Research Corporation (Texas Liver Institute)
RECRUITINGSan Antonio, Texas, 78215, United States
-
Clinical Pharmacology of Miami
RECRUITINGMiami, Florida, 33172, United States
-
Orlando Clinical Research Center
RECRUITINGOrlando, Florida, 32809, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test